Fatal Toxicities Vary by Immune Checkpoint Inhibitor Type

A study inJAMA Oncology found that a wide range of fatal toxic events can occur with immune checkpoint inhibitors, and the type of event varies by agent.

Source: CancerNetwork - October 16, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news